Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News ICAD Inc ICAD

Healthcare Medical Devices
iCAD, Inc. provides artificial intelligence-powered cancer detection. Its ProFound Breast Health Suite enables medical providers and professionals to accurately and reliably identify where cancer may be hiding. Its Cancer Detection segment solutions include advanced artificial intelligence and image analysis workflow solutions that enable healthcare professionals to better serve patients by... see more

Recent & Breaking News (NDAQ:ICAD)

iCAD Reports Financial Results for Third Quarter Ended September 30, 2024

GlobeNewswire 1 day ago

iCAD's ProFound Detection Version 4.0 Gains FDA Clearance

GlobeNewswire 3 days ago

iCAD to Attend 15th Annual Craig-Hallum Alpha Select Conference

GlobeNewswire 9 days ago

iCAD to Report Third Quarter 2024 Financial Results on November 13, 2024

GlobeNewswire 10 days ago

iCAD to Participate in the LD Micro Main Event XVII

Newsfile October 16, 2024

iCAD Highlights Global Availability of ProFound Cloud and International Expansion Milestones at JFR 2024

GlobeNewswire October 3, 2024

iCAD to Participate in the iAccess Alpha Buyside Best Ideas Fall Conference 2024

GlobeNewswire September 11, 2024

iCAD Reports Financial Results for Second Quarter Ended June 30, 2024 

GlobeNewswire August 13, 2024

iCAD to Report Second Quarter 2024 Financial Results on August 13, 2024

GlobeNewswire August 6, 2024

iCAD and Windsong Radiology Announce Strategic Commercial Agreement to Implement AI-Powered Mammography

GlobeNewswire July 29, 2024

iCAD to Highlight Promising Research on Potential of its AI Algorithm to More Accurately Identify and Personalize Breast Cancer Risk at SIIM 2024

GlobeNewswire June 26, 2024

iCAD to Participate in the MedInvest MedTech, AI & Digital Health Conference

GlobeNewswire June 4, 2024

iCAD Reports Financial Results for First Quarter Ended March 31, 2024

GlobeNewswire May 15, 2024

UPDATE - iCAD to Report First Quarter 2024 Financial Results on May 15, 2024

GlobeNewswire May 8, 2024

iCAD to Report First Quarter 2024 Financial Results on May 15, 2024

GlobeNewswire May 2, 2024

iCAD Showcases New ProFound Cloud, Enhanced ProFound Detection Workstation Features and New Strategic Partnerships at SBI Annual Symposium

GlobeNewswire April 11, 2024

iCAD and Densitas Partner to Enhance Precision Breast Health with Leading AI Solutions for Mammography Quality, Cancer Detection, and Risk Evaluation

GlobeNewswire April 9, 2024

iCAD's ProFound AI Suite Uncovers Hidden Heart Disease Risk According to New Data Presented at American College of Cardiology Meeting

GlobeNewswire April 8, 2024

iCAD Partners with RAD-AID to Advance Breast Cancer Detection Using AI in Underserved Regions and Low- and Middle-Income Countries (LMICs)

GlobeNewswire April 3, 2024

iCAD Unveils ProFound Cloud, Enabling Interoperability and Access to Breast AI Solutions at Enterprise Scale

GlobeNewswire April 2, 2024